Amplifying RNA Vaccine Development

N Engl J Med. 2020 Jun 18;382(25):2469-2471. doi: 10.1056/NEJMcibr2009737.

Authors

Deborah H Fuller¹, Peter Berglund¹

Affiliation

¹ From the Department of Microbiology, University of Washington School of Medicine (D.H.F.), and HDT Bio (P.B.) - both in Seattle.

PMID: 32558474
DOI: 10.1056/NEJMcibr2009737

No abstract available

MeSH terms

Animals
Betacoronavirus / genetics*
COVID-19
Coronavirus Infections / prevention & control*
Gene Amplification
Humans
Mice
Nucleic Acid Amplification Techniques
Orthomyxoviridae Infections / immunology
Orthomyxoviridae Infections / prevention & control*
Pandemics / prevention & control*
Pneumonia, Viral / prevention & control*
RNA, Messenger / administration & dosage
RNA, Messenger / immunology*
RNA, Viral / genetics
RNA, Viral / physiology*
RNA-Dependent RNA Polymerase / genetics*
RNA-Dependent RNA Polymerase / physiology
SARS-CoV-2
Viral Vaccines*

Substances

RNA, Messenger
RNA, Viral
Viral Vaccines
RNA-Dependent RNA Polymerase